Can your PM patients have an MRI?

SureScan® Pacing Systems

Before the MRI Scan

More on MRI & Devices

Advisa MRI™ SureScan® Pacemaker


Second generation SureScan® pacemaker provides leading-edge pacing technology that can be used safely in a MRI environment.

Advisa MRI™ SureScan™ Pacemaker photoWhat should you expect in today’s leading-edge pacing system? A system that can benefit patients tomorrow as well.

The Advisa MRI™ pacing system is designed for safe access to MRI diagnostic imaging with SureScan® and unparalleled disease insight and management for your patients today. Plus it has the tools to diagnose and manage the co-morbidities they may develop tomorrow. Our most advanced Advisa MRI™ pacing system provides your patients unsurpassed capabilities. Innovative features like MVP®, OptiVol®, digital diagnostics and a complete suite of atrial therapies.

Innovation. Sophistication. Simplicity. With no compromise.

SureScan® is designed for safe access to MRI, an unparalleled diagnostic imaging
For millions of patients with cardiac devices, MRI scans are unsafe and contraindicated. 50%–75% of patients with an implantable cardiac device will need an MRI scan over the lifetime of their device. SureScan® pacing systems are the first pacing systems — consisting of the pacemaker and leads — that are designed, tested, and CE Mark-approved for full body MRI scans when used according to labeling.

Managed Ventricular Pacing (MVP®)
Unnecessary right ventricular (RV) pacing increases the risk of Atrial Fibrillation (AF), Heart Failure hospitalisation, and mortality. The ESC Guidelines state that in the selection of pacing mode and device, “the trend is towards dual chamber pacing with minimisation of right ventricular stimulation” and the ACC/AHA/HRS guidelines also recognised the importance of minimising unnecessary RV pacing. Managed Ventricular Pacing (MVP®) is proven to reduce unnecessary RV pacing by 99%.13

Full Automaticity — proven safe, simple, and accurate
Fully automatic pacemaker follow-up means more time with patients, less time with devices. Atrial and Ventricular Capture Management™ (ACM and VCM) provide confidence in your patients’ safety with automatic threshold measurements and adjustments. TherapyGuide® offers easy, patient tailored nominal programming.

Cardiac Compass® Trends provide clear information for detecting atrial arrhythmias and for rapid decision making.

22 minutes of dual channel high quality stored EGM.

OptiVol® Fluid Status Monitoring tracks and monitors fluid changes using intrathoracic impedance measurements.

Carelink® Network allows remote device follow-up by transmitting comprehensive arrhythmia and diagnostic data right to your clinic.

Atrial tachyarrhythmia tools help in the early detection and management of AF.

Rate Drop Response identifies abrupt cardiac slowing and responds by pacing the heart at an elevated rate.

High Upper Tracking Rates up to 210 bpm are beneficial for your pediatric patients as well as young and active patients.


Brochure

download file

 PDFAdvisa MRI™ Overview Brochure
 English


Manuals

Clinician Manual
Advisa MRI Clinician Manual

MRI Technical Manual (MRI procedural information)
For applicable countries, the MRI Technical Manual has been updated to include MR conditional use of specific SureScan lead models. To choose the manual appropriate for your country, please do the following:

Geography-Specific Note:
South Korea: The MR Conditions of Use include a patient positioning restriction within the MRI bore (Isocenter cannot be placed between C1 and T12). Please refer to the SureScan Technical Manual (South Korea) for the complete set of MRI Conditions of Use.

Product Availability
The SureScan® Pacing System may not be available in your country. Please contact your local Medtronic sales representative for more information.

Brief Statement
Approved for MR-conditional use. See the device manual for detailed information regarding the implant procedure, indications, contraindications, warnings, precautions, potential adverse events, and MR specific conditions for use.